Pages:
- Donate
- Register
- Support for Health Professionals
- Support for PALS & CALS
- Advocacy
- Fundamental Rights for People with ALS/MND and Caregivers
- Research
- Clinical Care
- Global Clinic Locator
- Genetic Counselling & Testing
- Genetic Roundtable Resources
- Mental Health Support
- Nursing and Symptom Management
- Nutrition and Swallowing
- Occupational Therapy and Activities of Daily Living
- Physiotherapy and Mobility
- Respiratory Care
- Speech Therapy and Communication
- Support for Family & Caregivers
- Technology
- Approved Drugs
- Drugs in Development
- AB Science – Masitinib
- Neuronata-R/Lenzumestrocel
- Neuvivo – NP001
- Prilenia Therapeutics – Pridopidine
- BrainStorm Cell Therapeutics – NurOwn
- Clene Nanomedicine – CNM-Au8
- Collaborative Medicinal Development – CuATSM
- Kadimastem – AstroRx
- ILB – Tikomed
- Methylcobalamin
- Oral Edaravone
- NeuroSense – PrimeC
- SOD1 Therapies & Trials
- T Regulatory Cell Therapies
- Drugs No Longer in Development
- About the Alliance
- Contact Us
- Disclaimer
- Events/Programs
- Find ALS/MND associations around the world
- International Alliance of ALS/MND Associations
- Join the Alliance
- Make a donation
- Newsletter subscription
- Privacy notice & Cookies
- Sitemap
- What is ALS/MND?
- Member Roundtables
- 2026 Calendar Project
- March of Faces
- Member Webinars
- Submit an Event
- Submit a Resource
- Become A Mentor
- Become A Mentee